West Branch Capital’s Cognex CGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-170
Closed -$5.07K – 484
2025
Q1
$5.07K Hold
170
– – ﹤0.01% 345
2024
Q4
$6.1K Hold
170
– – ﹤0.01% 322
2024
Q3
$6.88K Hold
170
– – ﹤0.01% 311
2024
Q2
$7.95K Hold
170
– – ﹤0.01% 290
2024
Q1
$7.21K Hold
170
– – ﹤0.01% 303
2023
Q4
$7.1K Hold
170
– – ﹤0.01% 306
2023
Q3
$7.21K Hold
170
– – ﹤0.01% 302
2023
Q2
$9.52K Hold
170
– – ﹤0.01% 286
2023
Q1
$8.42K Hold
170
– – ﹤0.01% 304
2022
Q4
$8.01K Hold
170
– – ﹤0.01% 302
2022
Q3
$7K Hold
170
– – ﹤0.01% 309
2022
Q2
$7K Hold
170
– – ﹤0.01% 302
2022
Q1
$13K Hold
170
– – 0.01% 268
2021
Q4
$13K Hold
170
– – 0.01% 298
2021
Q3
$14K Hold
170
– – 0.01% 273
2021
Q2
$14K Buy
+170
New +$13.8K 0.01% 288

Other funds holding CGNX

West Branch Capital's CGNX Position: Q2 2025 in Review

West Branch Capital sold out of Cognex (CGNX) in Q2 2025, closing a stake of 170 shares — an estimated $5.07K sold.

West Branch Capital first reported a position in CGNX in Q2 2021 and held it in 16 quarters. The position peaked at $14K in Q3 2021. 460 funds tracked by Wall St. Rank hold CGNX as of Q2 2025.

  • West Branch Capital reported no remaining Cognex position as of Q2 2025 after selling out during the quarter.
  • West Branch Capital sold 170 Cognex shares in Q2 2025, an estimated $5.07K.
  • West Branch Capital first reported a position in Cognex in Q2 2021 and held it in 16 quarters.
  • West Branch Capital's Cognex position peaked at $14K in Q3 2021.
  • 460 funds tracked by Wall St. Rank held Cognex as of Q2 2025.

Based on West Branch Capital's 13F filing for Q2 2025, filed 16 Jul 2025.